Evidence map›Paper›PMID 42102196›Full record

ArticleScience advances2026

Protein language models accurately predict polymorphic peptide-modulated NK cell receptor-HLA class I interaction strengths.

Abdallah AlShafey, Madeline Nelson, Mubasher Hassan, Andrzej Kloczkowski, William Ray, Salim I Khakoo, Jayajit Das

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdallah AlShafeySteve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0002-0634-9890
Madeline NelsonInformation and Technology Research and Innovation, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0009-0005-0948-1407
Mubasher HassanSteve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0003-2532-1866
Andrzej KloczkowskiSteve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0003-1002-5095
William RayInformation and Technology Research and Innovation, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0002-4207-250X
Salim I KhakooSchool of Clinical and Experimental Sciences, University of Southampton, Southampton SO17 1BJ, UK.ORCID 0000-0002-4057-9091
Jayajit DasSteve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.ORCID 0000-0001-9649-4698

Funding

Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)R01AI146581 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI DAS, JAYAJIT · 2020 to 2025
$2.3M
Developing a predictive in silico toolkit for modeling NK cell responses against RNA virus infectionsR01AI143740 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI DAS, JAYAJIT · 2019 to 2023
$1.5M
NIAID NIH HHS R01 AI143740NIAID NIH HHS R01 AI146581
6 · The paper itself

Abstract

Killer-cell immunoglobulin-like receptors (KIRs) are key determinants of natural killer cell function and are associated with the outcomes of infective, inflammatory, and neoplastic diseases. They form a polymorphic family of activating and inhibitory receptors that interact with polymorphic class I human leukocyte antigen (HLA-I) molecules. This interaction is dependent on the short peptides bound by the HLA-I molecules, including those derived from viruses and cancers. Identifying these peptides among the vast space of possible peptides based on the sequences of the interacting molecules can provide a valuable tool for developing personalized immunotherapy against infection and cancer. To address this challenge, we leveraged foundation protein language models and trained our model on available datasets for KIR-binding peptide-HLA complexes. Our tool generated excellent predictions with an area under receiver operator characteristic (AUROC) >0.8 for the majority of inhibitory KIRs and performed well (AUROC >0.7) for peptides generated during HIV and HCV infections. Our model holds substantial potential for advancing our understanding of immune regulation and the biophysical factors responsible for it, paving the way for KIR-specific therapeutic interventions.

Indexed as

Histocompatibility Antigens Class IKiller Cells, NaturalPeptidesReceptors, KIRReceptors, Natural Killer CellHumansModels, MolecularProtein BindingHistocompatibility Antigens Class IPeptidesReceptors, KIRReceptors, Natural Killer Cell

Identifiers

PMID42102196
PMCPMC13155296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.